Founder, President, Chief Scientific Officer and Chairman of the Board.
Dr. Roninson developed functional genomics techniques for high-throughput target discovery, cloned the gene responsible for the major form of multidrug resistance in cancer, and was responsible for the discovery of the first selective CDK8/19 inhibitors and the identification of their unique activities in cancers. Dr. Roninson is Director of the Center for Targeted Therapeutics, SmartState Endowed Chair and Professor at the University of South Carolina. In the past, he served as the Director of the Cancer Center at Ordway Research Institute, Albany, New York and Distinguished Professor of Molecular Genetics and Head of the Division of Molecular Oncology, University of Illinois at Chicago. Dr. Roninson has authored over 175 articles and book chapters (H-index 79) and is an inventor of 47 issued US patents.